Biotechnology Headlines from PR Newswire

< Go Back

Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing
WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax
Novocure™ Enrolls First Patient in a Pilot Study of Tumor Treating Fields (TTFields) Together with Paclitaxel for the Treatment of Recurrent Ovarian Cancer
Regado Biosciences to Provide Third Quarter 2014 Financial Results
WHEATON® Highlights Unique Products at AAPS 2014 Providing Purpose-Built Solutions for the Pharmaceutical Industry
New report shows Indiana's gains in life sciences innovation capital outpace the nation
Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference
Can-Fite to Participate in BIO-Europe International Partnering Conference
Omidria™ Granted Pass-Through Reimbursement Status from CMS
NeoGenomics Reports 38% increase in Revenue to a Record $23.2 Million and Adjusted EBITDA of $2.6 Million for the Third Quarter of 2014
HeartWare International Reports $68.6 Million In Third Quarter 2014 Revenue; 25% Increase From Third Quarter 2013 iPSC Research Products Continue 14.7% Annual Growth During Human Clinical Trials, According to BioInformant Report
CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium
New Data on Fatigue from ROMANA 1, a Pivotal Phase III Study of Anamorelin in Advanced NSCLC Patients with Cachexia Presented at 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology
Kiadis Pharma's Lead Product ATIR™ Granted Orphan Drug Designation by EMA for the Treatment of Acute Myeloid Leukemia
Lilly Shares Insights from Decade-Long Technology Transfer Experience
Hemoglobin A1c Testing Devices Market (End-use - Laboratory and Point-of-Care Testing Devices; Technologies - Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay and Others) - Global Industry Analysis, Size, Shar
Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Flublok® Influenza Vaccine Now Approved for Adults Ages 18 and Older
New Research Study Shows the Value of Neonics
CTI BioPharma Reports Third Quarter 2014 Financial Results
QIAGEN Reports Results for Third Quarter and First Nine Months of 2014
NeuroDerm Announces Positive Topline Results of Phase II, Placebo-Controlled Study of Continuous, Subcutaneously Delivered Levodopa/Carbidopa (ND0612L) in Patients with Moderate to Severe Parkinson's Disease
IBM and Cleveland Clinic Use Watson to Advance Genomic Research for Cancer Care Pilot English
Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014
Cell Expansion Market Worth $14.8 Billion by 2019
Global and Chinese Molecular Diagnostics Equipment Industry Report 2014
Neuland Labs Reports Second Quarter Fiscal Year 2015 Financial Results
The Galien Foundation Honors Excellence in Scientific Innovation and Humanitarian Efforts at 2014 Prix Galien Awards Gala
James Forte Joins Kineticos as Managing Director
ViaCyte's VC-01™ Investigational Stem Cell-Derived Islet Replacement Therapy Successfully Implanted into First Patient
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin
PlasmaTech Biopharmaceuticals Appoints World Leading Plasma Experts to Scientific Advisory Board
MEI Pharma Advances Clinical Study Of Mitochondrial Inhibitor ME-344 In Small Cell Lung And Ovarian Cancers
Trovagene Schedules Release of Third Quarter 2014 Financial Results and Investor Conference Call
Wyss Institute launches 'SLIPS' company English
PTC Therapeutics to Present at the Credit Suisse 23rd Annual Healthcare Conference
Celsion Presents Preclinical Data for its TheraSilence™ Platform at the miRNA World Conference Workshop on miRNA Delivery
Discovery Labs to Report 2014 Third Quarter Financial Results and Hold Conference Call on Thursday, November 6, 2014 at 9:00 a.m. Eastern Time
Veracyte, Inc. Announces New Data Supporting Clinical Validity of Afirma® Gene Expression Classifier
Synageva BioPharma to Present at the Nomura Biotechnology Conference
CytRx Announces Publication of Preclinical Glioblastoma Data in Neoplasia
PCR Technologies Global market - Forecast to 2020
Global Laboratory Centrifuges Market 2014-2018
Ambit Announces Expiration of Hart-Scott-Rodino Waiting Period
AtheroNova Prices Public Offering of Common Stock and Warrants
Express Scripts Announces 3rd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point
Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
QIAGEN Announces Broad Agreement With Astellas Pharma to Develop Companion Diagnostics
Cambrex to Announce Third Quarter 2014 Financial Results on October 30, 2014

< Prev Next >
PR Newswire - United Business Media